Botox 100 unit vials
Ended Awarded
- Contract number
- SPE2DB25FUJSE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,251
Award facts
- Contract value 100% obligated
- $9,251.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded a delivery order valued at $9,251.40 by the Defense Logistics Agency on September 16, 2025, for the supply of BOTOX 100 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of October 7, 2025, and carries no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that authorizes the agency to issue delivery orders for comprehensive pharmaceutical products supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively for DLA contracts. The company's extensive portfolio includes branded and generic prescription drugs, biologics, and medical consumables spanning multiple therapeutic categories. This particular delivery order for BOTOX represents a routine procurement within the company's established relationship with the Defense Logistics Agency, reflecting the ongoing pharmaceutical supply needs of the Department of Defense healthcare system.
Quick answers
Who was awarded contract SPE2DB25FUJSE?
SPE2DB25FUJSE was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FUJSE worth?
The government has obligated $9,251 on SPE2DB25FUJSE.
Is contract SPE2DB25FUJSE an order under another contract?
Yes. SPE2DB25FUJSE is a delivery order under SPE2DB25D9365, an indefinite delivery contract.
Was contract SPE2DB25FUJSE competed?
The extent of competition for SPE2DB25FUJSE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award